Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The document concludes that more research is needed to fully understand the causes of PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Hormonal therapies are safe and effective for treating adult women's acne.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.